Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability

por Shubin, Zhanna, Stanfield-Oakley, Sherry, Puangkaew, Jiraporn, Pitisutthithum, Punnee, Nitayaphan, Sorachai, Gurunathan, Sanjay, Sinangil, Faruk, Chariyalertsak, Suwat, Phanuphak, Nittaya, Ake, Julie A., O’Connell, Robert J., Vasan, Sandhya, Akapirat, Siriwat, Eller, Michael A., Ferrari, Guido, Paquin-Proulx, Dominic
Publicado 2023

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

por Karnasuta, Chitraporn, Akapirat, Siriwat, Madnote, Sirinan, Savadsuk, Hathairat, Puangkaew, Jiraporn, Rittiroongrad, Surawach, Rerks-Ngarm, Supachai, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., de Souza, Mark S., Michael, Nelson L., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J., Karasavvas, Nicos
Publicado 2017

Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations

por Akapirat, Siriwat, Karnasuta, Chitraporn, Vasan, Sandhya, Rerks-Ngarm, Supachai, Pitisuttithum, Punnee, Madnote, Sirinan, Savadsuk, Hathairat, Rittiroongrad, Surawach, Puangkaew, Jiraporn, Phogat, Sanjay, Tartaglia, James, Sinangil, Faruk, de Souza, Mark S., Excler, Jean-Louis, Kim, Jerome H., Robb, Merlin L., Michael, Nelson L., Ngauy, Viseth, O'Connell, Robert J., Karasavvas, Nicos
Publicado 2018